The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.

×

Search

×
08 Mar 2019

Federal funding over three years to 2022 will see an extra $268 million given to Primary Health Networks (PHNs) and other organisations to help with the fight against alcohol and drug abuse.

PHNs, providers of residential and non-residential withdrawal management and rehabilitation programs, alcohol and peak drug organisations and other national activities already supported by our Government will receive the money to help Australians suffering addiction.

From July 1 this year, PHNs will receive $45 million a year for alcohol and other drug treatment services, which will provide stability to services and meet the needs of local communities.

Withdrawal management and rehabilitation services currently receiving Government funding can apply for a share of $29 million a year in continued funding to provide evidence-based treatment services for individuals most in need.

Four national research centres will receive $24 million over three years to continue to undertake research into alcohol and other drug issues including the National Centre for Education and Training on Addiction, the National Drug and Alcohol Research Centre, the Centre for Youth Substance Research and the National Drug Research Institute.

Additionally, funding of $4.9 million a year will continue for alcohol and peak drug organisations and complementary national treatment sector capacity building activities.

Health Minister Greg Hunt said the funding announcement provides continuity of important drug and alcohol treatment and support services and complements state and territory funding.

As a new initiative, the Government has committed $7.2 million over two years to pilot a take-home naloxone (THN) program in Australia. Naloxone is a drug that can temporarily reverse opioid overdose.

In partnership with the States and Territories, a THN program will expand availability of naloxone to a range of additional settings frequently accessed by at-risk groups. Concurrent to the pilot, the Federal Government has provided more than $100,000 funding to the Burnett Institute to undertake research, with the National Drug Research Institute, into the key principles and features of a nationally consistent THN model in Australia.


Published: 08 Mar 2019